31Dec 2016

PREVALENCE OF MULTIPLE SCLEROSIS IN SAUDI ARABIA

  • Medical intern, Taibah University, Medina, Saudi Arabia.
  • Medical intern, Majmaah University, Majmaah, Saudi Arabia.
  • Medical intern, Jilin University, Changchun, China.
  • MBBS, MCPS, FCPS, Professor Dept of Community & Family Medicine, Taibah University, Al Medinah Munawara
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

This study aimed at detecting a rough estimation of the prevalence of multiple sclerosis among citizens of Saudi Arabia. Methodology: It is a cross sectional study purposed to estimate the prevalence of multiple sclerosis in KSA in 2016. It involved 633 individual from the society of Saudi Arabia. Results and conclusion: Most of the respondents (68.1%)were female, Also most of them (47.1%) aged between (20-24) , (94.5%) of them were Saudi national, the largest proportion of them (34.4%) live in the eastern region, (69.8%) of them hold a university degree, and (57.7%) of the respondents are single. Also, we found out that (66.2%) of the respondents don\\\'t know if they have MS or not, while (64.1%) of them don’t have relatives suffer from MS, as (24.3%) of the relatives who suffer from MS were cousins, and the most common suspicious symptom of MS was Fatigue Exhaustion as (6.8%) of the respondents have that symptom, also (96.4%) of the respondents don’t suffer from immune diseases, and most of those who suffer from immune diseases (26.1%) suffer from eczema. Also, (86.1%) of the respondents don’t suffer from Genetics diseases, while(18.2%) of the respondents who suffer from Genetic disease suffer from diabetes, and (71.7) of the respondents who suffer MS are females, while 49.1%) of the respondents who suffer MS aged between 25-35, (84.9%) of the respondents who suffer MS are Saudi national, and (39.6%) of the respondents who suffer MS live in the Objectives:-Central region, as (73.6%) of the respondents who suffer MS hold a university degree. The analysis illustrated that (64.2%) of the respondents who suffer from MS don’t have relatives suffer from MS, and (33.3 %) of the respondents who suffer from MS who have relatives suffer from MS have a mother suffers from MS, also (5.7%) of the respondents who suffer from MS have a symptom of Weakness in arm or leg, Numbness in the extremities, Loss of Balance or Fatigue Exhaustion, while (83.0%) of the respondents who suffer from MS don’t suffer from immune diseases, and (22.2 %) of the respondents who suffer from MS and immune diseases suffer from rhumatic fever or erthymatosis, as (96.2%) of the respondents who suffer from MS don’t suffer from Genetic disease, and (50%) of the respondents who suffer from MS and Genetics disease suffer from diabetes or hypertension. The results of analysis illustrated that there were statistically significant differences between those with and without MS as regard to age, nationality and the region (P<0.05), while there were no statistically significant differences as regard to gender, education and marital status(P>0.05). Also, MS was more prevalent between 25 and 30 years (49.1%), in Saudi nation (84.9%) and the central region (39.6%). Also, there were statistically significant differences at the level of significance (P <0.05), in the prevalence of MS in the relatives of the patients with and without MS in favor of no prevalence of MS in the relatives of (64.1%) patients with and without of respondents, We found that there were statistically significant differences between those with and without MS as regard to absence of suspicious symptoms of MS of Weakness in arm or leg, Loss of Balance and Anxiety (P<0.05), while there were no statistically significant differences as regard to Numbness in the extremities, Muscles Cramps, Walking Difficulty, Fatigue Exhaustion, Vertigo, Headache, Convulsion(Epilepsy), Vision Problems, Bladder Problems, Intestinal Problems, Sexual Problems, Depression and Memory and Thinking Problems (P>0.05).as most of the respondents stated the absence of Weakness in arm or leg (99.5%), Loss of Balance (99.5%) and Anxiety (99.8%). Finally, we indicated that there were statistically significant differences between those with and without MS as regard to absence of immune diseases and Genetics diseases (P<0.05), as (97.6%) of the respondents reported absence of immune diseases and (96.2%) of the respondents reported absence of Genetics diseases.


  1. Bargagli AM, Colais P, Agabiti N, et al. Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems. J Neurol. 2016;263(4):751-759. doi:10.1007/s00415-016-8049-8.
  2. Olek M. J., Narayan R.N., Frohman E.M. and Frohman T.C. (2016). Clinical features of multiple sclerosis in adults. In F.Gonzalez-Scarano, Howe J.P. and Dashe J.F (Eds.), UptoDate. Available from http://www.uptodate.com/contents/clinical-features-of-multiple-sclerosis-in-adults?source=see_link&sectionName=CLINICAL+SYMPTOMS+AND+SIGNS&anchor=H9#H9
  3. Bohlega S, Inshasi J, Al Tahan AR, Madani AB, Qahtani H, Rieckmann P. Multiple sclerosis in the Arabian Gulf countries: A consensus statement. J Neurol. 2013;260(12):2959-2963. doi:10.1007/s00415-013-6876-4.
  4. Ford HL, Gerry E, Johnson M, Williams R. A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds. J Neurol. 2002;249(3):260-265. doi:10.1007/s004150200002.
  5. Kingwell E, Zhu F, Marrie RA, et al. High prevalenceand increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991–2010). J Neurol. 2015;262(10):2352-2363. doi:10.1007/s00415-015-7842-0.
  6. Jick, S. S., Li, L., Falcone, G. J., Vassilev, Z. P., & Wallander, M. A. (2014). Mortality of patients with multiple sclerosis: a cohort study in UK primary care. Journal of neurology, 261(8), 1508-1517.
  7. Vatne A, Mygland A, Ljostad U. Multiple sclerosis in Vest-Agder County, Norway. Acta Neurol Scand 2011;123:396–9. doi:10.1111/j.1600-0404.2010.01411.x [PubMed]
  8. Risberg G, Aarseth JH, Nyland H, et al. Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway. Acta Neurol Scand 2011;124:250–7. doi:10.1111/j.1600-0404.2010.01465.x [PubMed]
  9. Berg-Hansen P, Moen SM, Harbo HF, et al. High prevalence and no latitude gradient of multiple sclerosis in Norway. Mult Scler 2014;20:1780–2. doi:10.1177/1352458514525871 [PubMed]
  10. Smestad C, Sandvik L, Holmoy T, et al. Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway. J Neurol 2008;255:49–55. doi:10.1007/s00415-007-0659-8 [PubMed]
  11. Mackenzie IS, Morant SV, Bloomfield GA, et al. Incidence and prevalence of multiple sclerosis in the UK 1990–2010: a descriptive study in the General Practice Research Database. J Neurol Neurosurg Psychiatry 2014;85:76–84. doi:10.1136/jnnp-2013-305450 [PMC free article] [PubMed]
  12. Bentzen J, Flachs EM, Stenager E, et al. Prevalence of multiple sclerosis in Denmark 1950–2005. Mult Scler 2010;16:520–5. doi:10.1177/1352458510364197 [PubMed]
  13. Ahlgren C, Oden A, Lycke J. High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler 2011;17:901–8. doi:10.1177/1352458511403794 [PubMed]
  14. Hirst C, Ingram G, Pickersgill T, et al. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 2009;80:386–91. doi:10.1136/jnnp.2008.144667 [PubMed]
  15. Visser EM, Wilde K, Wilson JF, et al. A new prevalence study of multiple sclerosis in orkney, Shetland and Aberdeen city. J Neurol Neurosurg Psychiatry 2012;83:719–24. [PubMed]
  16. Grytten N, Glad SB, Aarseth JH, et al. A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology 2006;66:182–6. doi:10.1212/01.wnl.0000195549.95448.b9 [PubMed]
  17. Larsen JP, Kvaale G, Riise T, et al. An increase in the incidence of multiple sclerosis in western Norway. Acta Neurol Scand 1984;70:96–103. doi:10.1111/j.1600-0404.1984.tb00809.x [PubMed]
  18. Larsen JP, Riise T, Nyland H, et al. Clustering of multiple sclerosis in the county of Hordaland, Western Norway. Acta Neurol Scand 1985;71:390–5. doi:10.1111/j.1600-0404.1985.tb03218.x [PubMed]
  19. Larsen JP, Aarli JA, Nyland H, et al. Western Norway, a high-risk area for multiple sclerosis: a prevalence/incidence study in the county of Hordaland. Neurology 1984;34:1202–7. doi:10.1212/WNL.34.9.1202 [PubMed]
  20. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520–32. doi:10.1016/S1474-4422(10)70064-8 [PubMed]
  21. Mayr WT, Pittock SJ, McClelland RL, et al. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000. Neurology 2003;61:1373–7. doi:10.1212/01.WNL.0000094316.90240.EB [PubMed]
  22. Marrie RA, Yu N, Blanchard J, et al. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 2010;74:465–71. doi:10.1212/WNL.0b013e3181cf6ec0 [PubMed]
  23. Cook SD, Cromarty JI, Tapp W, et al. Declining incidence of multiple sclerosis in the Orkney Islands. Neurology 1985;35:545–51. doi:10.1212/WNL.35.4.545 [PubMed]
  24. Joensen P. Multiple sclerosis: variation of incidence of onset over time in the Faroe Islands. Mult Scler 2011;17:241–4. doi:10.1177/1352458510386997 [PubMed]
  25. Svenningsson A, Runmarker B, Lycke J, et al. Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden. Acta Neurol Scand 1990;82:161–8. doi:10.1111/j.1600-0404.1990.tb04483.x [PubMed]
  26. Gray OM, McDonnell GV, Hawkins SA. Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland. Mult Scler 2008;14:880–6. doi:10.1177/1352458508090663 [PubMed]
  27. Warren SA, Svenson LW, Warren KG. Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada. Mult Scler 2008;14:872–9. doi:10.1177/1352458508089226 [PubMed]
  28. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227–31. doi:10.1002/ana.410130302 [PubMed]
  29. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005;58:840–6. doi:10.1002/ana.20703 [PubMed]
  30. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302. doi:10.1002/ana.22366 [PMC free article] [PubMed]
  31. Goodin DS, Reder AT, Ebers GC, et al. Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNbeta-1b trial. Neurology 2012;78:1315–22. doi:10.1212/WNL.0b013e3182535cf6 [PMC free article] [PubMed]
  32. Grytten Torkildsen N, Lie S, Aarseth J, et al. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway. Mult Scler 2008;14:1191–8. doi:10.1177/1352458508093890 [PubMed]
  33. Orton SM, Wald L, Confavreux C, et al. Association of UV radiation with multiple sclerosis prevalence and sex ratio in France. Neurology 2011;76:425–31. doi:10.1212/WNL.0b013e31820a0a9f [PMC free article] [PubMed]
  34. Debouverie M, Pittion-Vouyovitch S, Louis S, et al. Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France. Mult Scler 2007;13:962–7. doi:10.1177/1352458507077938 [PubMed]
  35. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007;61:288–99. doi:10.1002/ana.21117 [PubMed]
  36. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 2007;61:504–13. doi:10.1002/ana.21141 [PubMed]
  37. Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013;496:518–22. doi:10.1038/nature11868 [PMC free article] [PubMed]
  38. Bjørnevik K, Riise T, Casetta I, et al. Sun exposure and multiple sclerosis risk in Norway and Italy: the EnvIMS study. Mult Scler 2014;20:1042–9. doi:10.1177/1352458513513968 [PubMed]
  39. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832–8. doi:10.1001/jama.296.23.2832 [PubMed]

[Maryam Alshanqiti, Fawaz Fahad Alotaibi, Jafer Mohammed Alahmed, Marwah Lafi Alrehaili, Salwa Saleem Alalwi and Dr. Farah Mansuri (2016); PREVALENCE OF MULTIPLE SCLEROSIS IN SAUDI ARABIA Int. J. of Adv. Res. 4 (Dec). 1581-1600] (ISSN 2320-5407). www.journalijar.com


Maryam Alshanqiti
Medical Intern, Taibah University

DOI:


Article DOI: 10.21474/IJAR01/2560      
DOI URL: http://dx.doi.org/10.21474/IJAR01/2560